{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:40:23Z","timestamp":1786981223612,"version":"build-2736575974"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10787-022-01040-9","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T13:02:38Z","timestamp":1660136558000},"page":"1503-1516","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pathogenic role of cytokines in COVID-19, its association with contributing co-morbidities and possible therapeutic regimens"],"prefix":"10.1007","volume":"30","author":[{"given":"Ayesha","family":"Tanveer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8380-7827","authenticated-orcid":false,"given":"Bushra","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzma","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Rasul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aftab","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashif","family":"Jilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"1040_CR1","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jpeds.2020.04.049","volume":"222","author":"EM Abrams","year":"2020","unstructured":"Abrams EM, Szefler SJ (2020) Managing asthma during coronavirus disease-2019: an example for other chronic conditions in children and adolescents. J Pediatr 222:221\u2013226. https:\/\/doi.org\/10.1016\/j.jpeds.2020.04.049","journal-title":"J Pediatr"},{"issue":"4","key":"1040_CR2","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mjafi.2020.08.004","volume":"76","author":"U Agrawal","year":"2020","unstructured":"Agrawal U, Raju R, Udwadia ZF (2020) Favipiravir: a new and emerging antiviral option in COVID-19. Med J Armed Forces Ind 76(4):370\u2013376","journal-title":"Med J Armed Forces Ind"},{"issue":"7","key":"1040_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3389\/fmed.2020.00480","volume":"31","author":"MJ Ali","year":"2020","unstructured":"Ali MJ, Hanif M, Haider MA, Ahmed MU, Sundas F, Hirani A, Khan IA, Anis K, Karim AH (2020) Treatment options for COVID-19: a review. Front Med 31(7):480","journal-title":"Front Med"},{"issue":"14","key":"1040_CR4","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2020.2565","volume":"323","author":"Y Bai","year":"2020","unstructured":"Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, Wang M (2020) Presumed asymptomatic carrier transmission of COVID-19. JAMA 323(14):1406\u20131407","journal-title":"JAMA"},{"key":"1040_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/B978-012079028-9\/50110-1","volume-title":"Asthma and COPD","author":"PJ Barnes","year":"2002","unstructured":"Barnes PJ, Drazen JM (2002) Pathophysiology of asthma. Asthma and COPD. Elsevier, Amsterdam, pp 343\u2013359"},{"key":"1040_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cyto.2013.04.036","volume":"63","author":"E Bartee","year":"2013","unstructured":"Bartee E, McFadden G (2013) Cytokine synergy: an underappreciated contributor to innate anti-viral immunity. Cytokine 63:237\u2013240","journal-title":"Cytokine"},{"issue":"6","key":"1040_CR7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1097\/01.ede.0000181633.80269.4c","volume":"16","author":"CT Bauch","year":"2005","unstructured":"Bauch CT, Lloyd-Smith JO, Coffee MP, Galvani AP (2005) Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology 16(6):791\u2013801","journal-title":"Epidemiology"},{"key":"1040_CR8","first-page":"635","volume":"4","author":"JA Baugh","year":"2001","unstructured":"Baugh JA, Bucala R (2001) Mechanisms for modulating TNF alpha in immune and inflammatory disease. Curr Opin Drug Discov Dev 4:635\u2013650","journal-title":"Curr Opin Drug Discov Dev"},{"key":"1040_CR9","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/S0140-6736(07)60750-8","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Carding SR (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369:1627\u20131640","journal-title":"Lancet"},{"issue":"9998","key":"1040_CR10","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(15)00156-7","volume":"386","author":"R Beasley","year":"2015","unstructured":"Beasley R, Semprini A, Mitchell EA (2015) Risk factors for asthma: is prevention possible? Lancet 386(9998):1075\u20131085","journal-title":"Lancet"},{"key":"1040_CR11","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.1073\/pnas.0809524106","volume":"106","author":"S Belouzard","year":"2009","unstructured":"Belouzard S, Chu VC, Whittaker GR (2009) Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci USA 106:5871\u20135876","journal-title":"Proc Natl Acad Sci USA"},{"key":"1040_CR12","doi-asserted-by":"publisher","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","volume":"77","author":"BJ Bosch","year":"2003","unstructured":"Bosch BJ, van der Zee R, de Haan CA, Rottier PJ (2003) The coronavirus spike protein is a class i virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 77:8801\u20138811","journal-title":"J Virol"},{"key":"1040_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2174\/1389203043379378","volume":"5","author":"M Caraglia","year":"2004","unstructured":"Caraglia M, Vitale G, Marra M, Budillon A, Tagliaferri P, Abbruzzese A, Science P (2004) Alpha-interferon and Its effects on signalling pathways within cells. Curr Protein Pept Sci 5:475\u2013485","journal-title":"Curr Protein Pept Sci"},{"key":"1040_CR14","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.00102-14","volume":"28","author":"JF Chan","year":"2015","unstructured":"Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen K-Y (2015) Middle east respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev 28:465\u2013522","journal-title":"Clin Microbiol Rev"},{"key":"1040_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF Chan","year":"2020","unstructured":"Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY (2020) A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395:514\u2013523","journal-title":"Lancet"},{"key":"1040_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s12026-014-8534-z","volume":"59","author":"R Channappanavar","year":"2014","unstructured":"Channappanavar R, Zhao J, Perlman SJIR (2014) T cell-mediated immune response to respiratory coronaviruses. Immunol Res 59:118\u2013128","journal-title":"Immunol Res"},{"key":"1040_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104673","volume":"150","author":"S Choudhary","year":"2021","unstructured":"Choudhary S, Sharma K, Silakari O (2021) The interplay between inflammatory pathways and COVID-19: a critical review on pathogenesis and therapeutic options. Microb Pathog 150:104673","journal-title":"Microb Pathog"},{"key":"1040_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/thorax.2003.012658","volume":"59","author":"C Chu","year":"2004","unstructured":"Chu C, Cheng V, Hung I, Wong M, Chan K, Chan K, Kao R, Poon L, Wong C, Guan Y (2004) Role of lopinavir\/ritonavir in the treatment of sars: initial virological and clinical findings. Thorax 59:252\u2013256","journal-title":"Thorax"},{"key":"1040_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejps.2014.02.014","volume":"58","author":"E Conte","year":"2014","unstructured":"Conte E, Gili E, Fagone E, Fruciano M, Iemmolo M, Vancheri C (2014) Effect of pirfenidone on proliferation TGF-\u03b2-Induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts. Eur J Pharm Sci 58:13\u201319","journal-title":"Eur J Pharm Sci"},{"key":"1040_CR20","first-page":"327","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti P, Ronconi G, Caraffa A, Gallenga C, Ross R, Frydas I, Kritas S (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 34:327\u2013331","journal-title":"J Biol Regul Homeost Agents"},{"key":"1040_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","volume":"30","author":"EA Coomes","year":"2020","unstructured":"Coomes EA, Haghbayan H (2020) Interleukin-6 in COVID-19: a systematic review and meta-analysis. Rev Med Virol 30:1\u20139","journal-title":"Rev Med Virol"},{"key":"1040_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jcrc.2020.03.005","volume":"57","author":"A Cortegiani","year":"2020","unstructured":"Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav SJ (2020) A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care 57:279\u2013283","journal-title":"J Crit Care"},{"key":"1040_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/BOR.0000000000000786","volume":"33","author":"KM D\u2019Silva","year":"2021","unstructured":"D\u2019Silva KM, Wallace ZS (2021) COVID-19 and rheumatoid arthritis. Curr Opin Rheumatol 33:255\u2013261","journal-title":"Curr Opin Rheumatol"},{"key":"1040_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"DJ Dhasmana","year":"2021","unstructured":"Dhasmana DJ (2021) Dexamethasone in hospitalized patients with Covid-19. New Engl J Med 384:693\u2013704","journal-title":"New Engl J Med"},{"key":"1040_CR25","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrmicro1930","volume":"6","author":"H Drakesmith","year":"2008","unstructured":"Drakesmith H, Prentice A (2008) Viral Infection and Iron Metabolism. Nat Rev Microbiol 6:541\u2013552","journal-title":"Nat Rev Microbiol"},{"key":"1040_CR26","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/14787210.2020.1813024","volume":"19","author":"D Echeverr\u00eda-Esnal","year":"2021","unstructured":"Echeverr\u00eda-Esnal D, Martin-Ontiyuelo C, Navarrete-Rouco ME, De-Antonio Cusco M, Ferr\u00e1ndez O, Horcajada JP, Grau S (2021) Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti-Infect Ther 19:147\u2013163","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"1040_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejca.2020.09.014","volume":"141","author":"K El Bairi","year":"2020","unstructured":"El Bairi K, Trapani D, Petrillo A, le Page C, Zbakh H, Daniele B, Belbaraka R, Curigliano G, Afqir S (2020) Repurposing anticancer drugs for the management of COVID-19. Eur J Cancer 141:40\u201361","journal-title":"Eur J Cancer"},{"key":"1040_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.smim.2014.09.011","volume":"26","author":"MP Etna","year":"2014","unstructured":"Etna MP, Giacomini E, Severa M, Coccia EM (2014) Pro-and anti-inflammatory cytokines in tuberculosis: a two-edged sword in TB pathogenesis. Semin Immunol 26:543\u2013551","journal-title":"Semin Immunol"},{"key":"1040_CR29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S1473-3099(20)30262-0","volume":"20","author":"EG Favalli","year":"2020","unstructured":"Favalli EG, Biggioggero M, Maioli G, Caporali R (2020) Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis 20:1012\u20131013","journal-title":"Lancet Infect Dis"},{"key":"1040_CR30","first-page":"1012","volume-title":"Coronaviruses","author":"AR Fehr","year":"2015","unstructured":"Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses. Springer, New York, pp 1012\u20131013"},{"key":"1040_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2020.120758","volume":"211","author":"H Filik","year":"2020","unstructured":"Filik H, Avan AA (2020) Electrochemical immunosensors for the detection of cytokine tumor necrosis factor alpha: a review. Talanta 211:120758","journal-title":"Talanta"},{"key":"1040_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","volume":"19","author":"JL Flynn","year":"2001","unstructured":"Flynn JL, Chan J (2001) Immunology of tuberculosis. Annu Rev Immunol 19:93","journal-title":"Annu Rev Immunol"},{"key":"1040_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2050-7771-1-5","volume":"1","author":"M Furqan","year":"2013","unstructured":"Furqan M, Mukhi N, Lee B, Liu D (2013) Dysregulation of JAK-STAT pathway in hematological malignancies and jak inhibitors for clinical application. Biomark Res 1:1\u201310","journal-title":"Biomark Res"},{"key":"1040_CR34","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S2213-2600(20)30225-3","volume":"8","author":"PM George","year":"2020","unstructured":"George PM, Wells AU, Jenkins RG (2020) Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 8:807\u2013815","journal-title":"Lancet Respir Med"},{"key":"1040_CR35","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1086\/315223","volume":"181","author":"NA Georgiou","year":"2000","unstructured":"Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ, van Asbeck BS (2000) Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis 181:484\u2013490","journal-title":"J Infect Dis"},{"key":"1040_CR36","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","volume":"383","author":"JD Goldman","year":"2020","unstructured":"Goldman JD, Lye DC, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn M-Y, Nahass RG (2020) Remdesivir for 5 or 10 days in patients with severe Covid-19. New Engl J Med 383:1827\u20131837","journal-title":"New Engl J Med"},{"key":"1040_CR37","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S0720-048X(98)00038-2","volume":"27","author":"W Grassi","year":"1998","unstructured":"Grassi W, de Angelis R, Lamanna G, Cervini C (1998) The clinical features of rheumatoid arthritis. Eur J Radiol 27:S18\u2013S24","journal-title":"Eur J Radiol"},{"key":"1040_CR38","doi-asserted-by":"publisher","first-page":"e3319","DOI":"10.1002\/dmrr.3319","volume":"36","author":"W Guo","year":"2020","unstructured":"Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, Qin R, Wang H, Shen Y, Du K (2020) Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metabolism Res Rev 36:e3319","journal-title":"Diabetes Metabolism Res Rev"},{"key":"1040_CR39","first-page":"39","volume":"64","author":"A Hamblin","year":"1988","unstructured":"Hamblin A (1988) Lymphokines and interleukins. J Immunol 64:39","journal-title":"J Immunol"},{"key":"1040_CR40","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/jmv.25943","volume":"92","author":"G He","year":"2020","unstructured":"He G, Wu J, Shi J, Gamber M, Jiang X, Sun W, Cai J (2020) COVID-19 in tuberculosis patients: a report of three cases. J Med Virol 92:1802\u20131806","journal-title":"J Med Virol"},{"key":"1040_CR41","first-page":"1059","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, Caricchio R, Mahmud S, Hazen MM, Halyabar O (2020) On the alert for cytokine storm: immunopathology in COVID-19. J Med Virol 72:1059\u20131063","journal-title":"J Med Virol"},{"key":"1040_CR42","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/bs.aivir.2016.08.004","volume":"96","author":"R Hulswit","year":"2016","unstructured":"Hulswit R, de Haan C, Bosch B-J (2016) Coronavirus spike protein and tropism changes. Adv Virus Res 96:29\u201357","journal-title":"Adv Virus Res"},{"key":"1040_CR43","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","volume":"395","author":"IF-N Hung","year":"2020","unstructured":"Hung IF-N, Lung K-C, Tso EY-K, Liu R, Chung TW-H, Chu M-Y, Ng Y-Y, Lo J, Chan J, Tam AR (2020) Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 395:1695\u20131704","journal-title":"Lancet"},{"key":"1040_CR44","doi-asserted-by":"publisher","first-page":"14614","DOI":"10.1128\/JVI.79.23.14614-14621.2005","volume":"79","author":"HP Jia","year":"2005","unstructured":"Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB Jr. (2005) ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol 79:14614\u201314621","journal-title":"J Virol"},{"key":"1040_CR45","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/v12040372","volume":"12","author":"Y Jin","year":"2020","unstructured":"Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, Duan G (2020) Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses 12:372","journal-title":"Viruses"},{"key":"1040_CR46","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/all.14348","volume":"75","author":"S Johnston","year":"2020","unstructured":"Johnston S (2020) Asthma and COVID-19: is asthma a risk factor for severe outcomes? Allergy 75:1543\u20131545","journal-title":"Allergy"},{"key":"1040_CR47","volume-title":"Diabetes: an old disease, a new insight","author":"K Kaul","year":"2013","unstructured":"Kaul K, Tarr JM, Ahmad SI, Kohner EM, Chibbe RJD (2013) Introduction to diabetes mellitus. Diabetes: an old disease, a new insight. Springer, New York"},{"issue":"80\u201388","key":"1040_CR48","first-page":"e8","volume":"146","author":"H Kimura","year":"2020","unstructured":"Kimura H, Francisco D, Conway M, Martinez FD, Vercelli D, Polverino F, Billheimer D, Kraft MJ (2020) Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J Allergy Clin Immunol 146(80\u201388):e8","journal-title":"J Allergy Clin Immunol"},{"key":"1040_CR49","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1128\/JVI.73.5.3737-3743.1999","volume":"73","author":"A Klausegger","year":"1999","unstructured":"Klausegger A, Strobl B, Regl G, Kaser A, Luytjes W, Vlasak RJ (1999) Identification of a coronavirus hemagglutinin-esterase with a substrate specificity different from those of influenza c virus and bovine coronavirus. J Virol 73:3737\u20133743","journal-title":"J Virol"},{"key":"1040_CR50","first-page":"1401","volume":"34","author":"JJ Koehorst","year":"2017","unstructured":"Koehorst JJ, van Dam JC, Saccenti E, dos Santos VAM (2017) GISAID Global initiative on sharing all influenza data phylogeny of SARS-like Betacoronaviruses including novel Coronavirus (nCoV). JMR Public Health Surveill 34:1401\u20131403","journal-title":"JMR Public Health Surveill"},{"key":"1040_CR51","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1099\/vir.0.055533-0","volume":"94","author":"SK Lau","year":"2013","unstructured":"Lau SK, Lau CC, Chan K-H, Li CP, Chen H, Jin D-Y, Chan JF, Woo PC, Yuen K-Y (2013) Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel middle east respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol 94:2679\u20132690","journal-title":"J Gen Virol"},{"key":"1040_CR52","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1056\/NEJMoa1310476","volume":"370","author":"EB Lee","year":"2014","unstructured":"Lee EB, Fleischmann R, Hall S, Wilkinson B, Bradley JD, Gruben D, Koncz T, Krishnaswami S, Wallenstein GV, Zang C (2014) Tofacitinib versus methotrexate in rheumatoid arthritis. New Eng J Med 370:2377\u20132386","journal-title":"New Eng J Med"},{"key":"1040_CR53","doi-asserted-by":"publisher","first-page":"100125","DOI":"10.1016\/j.waojou.2020.100125","volume":"13","author":"M Levin","year":"2020","unstructured":"Levin M, Ansotegui IJ, Bernstein J, Chang Y-S, Chikhladze M, Ebisawa M, Fiocchi A, Heffler E, Martin B, Morais-Almeida M (2020) Acute asthma management during SARS-CoV2-pandemic 2020. World Allergy Organ J 13:100125","journal-title":"World Allergy Organ J"},{"key":"1040_CR54","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Geng M, Peng Y, Meng L, Lu S (2020a) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 10:102\u2013108","journal-title":"J Pharm Anal"},{"key":"1040_CR55","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Geng M, Peng Y, Meng L, Lu S (2020b) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 10:102\u2013108","journal-title":"J Pharm Anal"},{"key":"1040_CR56","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/jmv.25801","volume":"92","author":"P Luo","year":"2020","unstructured":"Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J (2020) Tocilizumab treatment in COVID-19: a single center experience. J Med Virol 92:814\u2013818","journal-title":"J Med Virol"},{"key":"1040_CR57","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1084\/jem.177.5.1277","volume":"177","author":"F Mackay","year":"1993","unstructured":"Mackay F, Loetscher H, Stueber D, Gehr G, Lesslauer W (1993) Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 177:1277\u20131286","journal-title":"J Exp Med"},{"key":"1040_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3321","author":"E Maddaloni","year":"2020","unstructured":"Maddaloni E, Buzzetti R (2020) Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metabol Res Rev. https:\/\/doi.org\/10.1002\/dmrr.3321","journal-title":"Diabetes Metabol Res Rev"},{"key":"1040_CR59","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev.med.53.082901.103921","volume":"53","author":"L Maddox","year":"2002","unstructured":"Maddox L, Schwartz DA (2002) The pathophysiology of asthma. Annu Rev Med 53:477","journal-title":"Annu Rev Med"},{"key":"1040_CR60","first-page":"100029","volume":"2","author":"G Magro","year":"2020","unstructured":"Magro G (2020) SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6) the \u2018culprit lesion\u2019 of ARDS onset? What is there besides Tocilizumab? SGP130Fc. Cytokine 2:100029","journal-title":"Cytokine"},{"key":"1040_CR61","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S2213-2600(20)30127-2","volume":"8","author":"MA Matthay","year":"2020","unstructured":"Matthay MA, Aldrich JM, Gotts JE (2020) Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med 8:433\u2013434","journal-title":"Lancet Respir Med"},{"key":"1040_CR62","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G (2011) The Pathogenesis of rheumatoid arthritis. New Eng J Med 365:2205\u20132219","journal-title":"New Eng J Med"},{"key":"1040_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31180-6","volume-title":"RETRACTED: hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis","author":"MR Mehra","year":"2020","unstructured":"Mehra MR, Desai SS, Ruschitzka F, Patel AN (2020) RETRACTED: hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Elsevier, Amsterdam"},{"key":"1040_CR64","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/ecco-jcc\/jjaa061","volume":"14","author":"G Monteleone","year":"2020","unstructured":"Monteleone G, Ardizzone S (2020) Are patients with inflammatory bowel disease at increased risk for Covid-19 infection? J Crohn\u2019s Colitis 14:1334\u20131336","journal-title":"J Crohn\u2019s Colitis"},{"issue":"5","key":"1040_CR65","doi-asserted-by":"publisher","first-page":"E736","DOI":"10.1152\/ajpendo.00124.2020","volume":"318","author":"R Muniyappa","year":"2020","unstructured":"Muniyappa R, Gubbi S (2020) COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol, Endocrinol Metabol 318(5):E736\u2013E741","journal-title":"Am J Physiol, Endocrinol Metabol"},{"key":"1040_CR66","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1007\/s00253-015-6818-4","volume":"99","author":"TB Ng","year":"2015","unstructured":"Ng TB, Cheung RCF, Wong JH, Wang Y, Ip DTM, Wan DCC, Xia J (2015) Antiviral activities of whey proteins. Appl Microbiol Biotechnol 99:6997\u20137008","journal-title":"Appl Microbiol Biotechnol"},{"issue":"2","key":"1040_CR67","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5582\/bst.2020.03058","volume":"14","author":"M Ohe","year":"2020","unstructured":"Ohe M, Shida H, Jodo S, Kusunoki Y, Seki M, Furuya K, Goudarzi H (2020) Macrolide treatment for COVID-19: will this be the way forward? Biosci Trends 14(2):159\u2013160","journal-title":"Biosci Trends"},{"key":"1040_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15562-9","volume":"11","author":"X Ou","year":"2020","unstructured":"Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 11:1\u201312","journal-title":"Nat Commun"},{"key":"1040_CR69","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri1604","volume":"5","author":"LC Platanias","year":"2005","unstructured":"Platanias LC (2005) Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375\u2013386","journal-title":"Nat Rev Immunol"},{"key":"1040_CR70","first-page":"1","volume":"38","author":"E Prompetchara","year":"2020","unstructured":"Prompetchara E, Ketloy C, Palaga T (2020) Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 38:1\u20139","journal-title":"Asian Pac J Allergy Immunol"},{"key":"1040_CR71","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1165\/rcmb.2014-0445OC","volume":"54","author":"S Rangarajan","year":"2016","unstructured":"Rangarajan S, Kurundkar A, Kurundkar D, Bernard K, Sanders YY, Ding Q, Antony VB, Zhang J, Zmijewski J, Thannickal VJ (2016) Novel mechanisms for the antifibrotic action of nintedanib. Am J Respir Cell Mol Biol 54:51\u201359","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"1040_CR72","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1136\/ard.18.1.49","volume":"18","author":"AC Rheumatism","year":"1959","unstructured":"Rheumatism AC (1959) Diagnostic criteria for rheumatoid arthritis: revision 1958. Ann Rheum Dis 18(1):49","journal-title":"Ann Rheum Dis"},{"issue":"10223","key":"1040_CR73","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"P Richardson","year":"2020","unstructured":"Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J (2020) Baricitinib as potential treatment for nCoV acute respiratory disease. Lancet 395(10223):e30","journal-title":"Lancet"},{"issue":"6\u201313","key":"1040_CR74","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1053\/j.gastro.2020.04.002","volume":"159","author":"DT Rubin","year":"2020","unstructured":"Rubin DT, Abreu MT, Rai V, Siegel CA, Ahuja V, Allez M, Ananthakrishnan AN, Bernstein CN, Braun JG, Chowers Y (2020) Management of patients with Crohn\u2019s disease and ulcerative colitis during the coronavirus disease-2019 pandemic: results of an international meeting. Gastroenterology 159(6\u201313):e6","journal-title":"Gastroenterology"},{"key":"1040_CR75","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41584-020-0451-z","volume":"16","author":"G Schett","year":"2020","unstructured":"Schett G, Manger B, Simon D, Caporali R (2020) COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol 16:465\u2013470","journal-title":"Nat Rev Rheumatol"},{"key":"1040_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-017-0177-y","volume":"15","author":"F Seif","year":"2017","unstructured":"Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M (2017) The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal 15:1\u201313","journal-title":"Cell Commun Signal"},{"key":"1040_CR77","first-page":"8","volume":"8","author":"G Serrano","year":"2020","unstructured":"Serrano G, Kochergina I, Albors A, Diaz E, Oroval M, Hueso G, Serrano JM (2020) Liposomal lactoferrin as potential preventative and cure for COVID-19. Int J Res Health Sci 8:8\u201315","journal-title":"Int J Res Health Sci"},{"issue":"396","key":"1040_CR78","doi-asserted-by":"publisher","first-page":"eaal3653","DOI":"10.1126\/scitranslmed.aal3653","volume":"9","author":"TP Sheahan","year":"2017","unstructured":"Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, Leist SR, Pyrc K, Feng JY, Trantcheva I (2017) Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med 9(396):eaal3653","journal-title":"Sci Transl Med"},{"key":"1040_CR79","volume-title":"Pathophysiology of asthma","author":"B Sinyor","year":"2019","unstructured":"Sinyor B, Perez C (2019) Pathophysiology of asthma. StatPearls Publishing, Treasure Island"},{"key":"1040_CR80","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/ncb1038","volume":"5","author":"CA Sledz","year":"2003","unstructured":"Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR (2003) Activation of the interferon system by short-interfering RNAs. Nat Cell Biol 5:834\u2013839","journal-title":"Nat Cell Biol"},{"key":"1040_CR81","first-page":"3","volume":"56","author":"DR Spriggs","year":"1992","unstructured":"Spriggs DR, Deutsch S, Kufe DW (1992) Genomic structure, induction, and production of TNF-alpha. Immunol Ser 56:3\u201334","journal-title":"Immunol Ser"},{"issue":"12","key":"1040_CR82","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.amjmed.2021.07.004","volume":"134","author":"M St\u00e5hlberg","year":"2021","unstructured":"St\u00e5hlberg M, Reistam U, Fedorowski A, Villacorta H, Horiuchi Y, Bax J, Pitt B, Matskeplishvili S, L\u00fcscher TF, Weichert I (2021) Post-Covid-19 tachycardia syndrome: a distinct phenotype of post-acute covid-19 syndrome. Am J Med 134(12):1451\u20131456","journal-title":"Am J Med"},{"key":"1040_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03158-0","volume":"24","author":"A Stallmach","year":"2020","unstructured":"Stallmach A, Kortgen A, Gonnert F, Coldewey SM, Reuken P, Bauer M (2020) Infliximab against severe COVID-19-induced cytokine storm syndrome with organ failure\u2014a cautionary case series. Crit Care 24:1\u20133","journal-title":"Crit Care"},{"issue":"1","key":"1040_CR84","doi-asserted-by":"publisher","first-page":"2001708","DOI":"10.1183\/13993003.01708-2020","volume":"56","author":"C Stochino","year":"2020","unstructured":"Stochino C, Villa S, Zucchi P, Parravicini P, Gori A, Raviglione MC (2020) Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Euro Respir J 56(1):2001708","journal-title":"Euro Respir J"},{"key":"1040_CR85","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/S1357-2725(03)00259-0","volume":"36","author":"SE Sweeney","year":"2004","unstructured":"Sweeney SE, Firestein GS (2004) Rheumatoid arthritis: regulation of synovial inflammation. Int J Biochem Cell Biol 36:372\u2013378","journal-title":"Int J Biochem Cell Biol"},{"key":"1040_CR86","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, Macary PA, Ng LF (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20:363\u2013374","journal-title":"Nat Rev Immunol"},{"issue":"7428","key":"1040_CR87","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/S0140-6736(66)92364-6","volume":"287","author":"D Tyrrell","year":"1966","unstructured":"Tyrrell D, Bynoe M (1966) Cultivation of viruses from a high proportion of patients with colds. Lancet 287(7428):76\u201377","journal-title":"Lancet"},{"issue":"4","key":"1040_CR88","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.medmal.2020.04.002","volume":"50","author":"ZS Ulhaq","year":"2020","unstructured":"Ulhaq ZS, Soraya GV (2020) Interleukin-6 as a potential biomarker of COVID-19 progression. Med Maladies Infect 50(4):382","journal-title":"Med Maladies Infect"},{"key":"1040_CR89","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","volume":"395","author":"Z Varga","year":"2020","unstructured":"Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417\u20131418","journal-title":"Lancet"},{"key":"1040_CR90","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/BF02867979","volume":"17","author":"V Vijayan","year":"2002","unstructured":"Vijayan V (2002) Clinical aspects of tuberculosis. Int J Clin Biochem 17:96","journal-title":"Int J Clin Biochem"},{"key":"1040_CR91","first-page":"1","volume":"26","author":"AG Weber","year":"2020","unstructured":"Weber AG, Chau AS, Egeblad M, Barnes BJ, Janowitz T (2020) Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series. Mole Med 26:1\u20137","journal-title":"Mole Med"},{"key":"1040_CR92","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, M\u00fcller MA, Niemeyer D, Jones TC, Vollmar P, Rothe C (2020) Virological assessment of hospitalized patients with COVID-2019. Nature 581:465\u2013469","journal-title":"Nature"},{"key":"1040_CR93","volume-title":"Managing epidemics: key facts about major deadly diseases","author":"World Health Organization","year":"2018","unstructured":"World Health Organization (2018) Managing epidemics: key facts about major deadly diseases. World Health Organization, Geneva"},{"key":"1040_CR94","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8:420\u2013422","journal-title":"Lancet Respir Med"},{"key":"1040_CR95","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jinf.2006.01.005","volume":"54","author":"Yam LY-C, Lau AC-W, Lai FY-L, Shung E, Chan J, Wong V, Hong Kong Hospital Authority SARS Collaborative Group","year":"2007","unstructured":"Yam LY-C, Lau AC-W, Lai FY-L, Shung E, Chan J, Wong V, Hong Kong Hospital Authority SARS Collaborative Group (2007) Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong. J Infect 54:28\u201339","journal-title":"J Infect"},{"key":"1040_CR96","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1128\/AAC.01043-16","volume":"60","author":"M Yamamoto","year":"2016","unstructured":"Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue J-I, Matsuda Z (2016) Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome coronavirus s protein-mediated membrane fusion using the split-protein-based cell-cell fusion assay. Antimicrob Agents ChemotheR 60:6532\u20136539","journal-title":"Antimicrob Agents ChemotheR"},{"key":"1040_CR97","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the Cytokine Storm\u2019 in COVID-19. J Infect 80:607\u2013613","journal-title":"J Infect"},{"key":"1040_CR98","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1128\/JVI.01792-08","volume":"83","author":"T Yoshikawa","year":"2009","unstructured":"Yoshikawa T, Hill T, Li K, Peters CJ, Tseng C-TK (2009) Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells. J Virol 83:3039\u20133048","journal-title":"J Virol"},{"key":"1040_CR99","doi-asserted-by":"publisher","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","volume":"215","author":"K Yuki","year":"2020","unstructured":"Yuki K, Fujiogi M, Koutsogiannaki S (2020) COVID-19 pathophysiology: a review. Clin Immunol 215:108427\u2013108427","journal-title":"Clin Immunol"},{"key":"1040_CR100","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2020.04.046","volume":"87","author":"J Zhang","year":"2020","unstructured":"Zhang J, Xie B, Hashimoto K (2020a) Current status of potential therapeutic candidates for the COVID-19 crisis. Brain Behav Immunity 87:59\u201373","journal-title":"Brain Behav Immunity"},{"key":"1040_CR101","doi-asserted-by":"publisher","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","volume":"214","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, Wang J, Qin Y, Zhang X, Yan X (2020b) The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol 214:108393","journal-title":"Clin Immunol"},{"key":"1040_CR102","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijid.2020.01.050","volume":"92","author":"S Zhao","year":"2020","unstructured":"Zhao S, Lin Q, Ran J, Musa SS, Yang G, Wang W, Lou Y, Gao D, Yang L, He D (2020) Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: a data-driven analysis in the early phase of the outbreak. Int J Infect Dis 92:214\u2013217","journal-title":"Int J Infect Dis"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-01040-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01040-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:27:26Z","timestamp":1668644846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-01040-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1040"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-01040-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"13 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}